Intended for healthcare professionals

Radiotherapy and dermatology

Charles Kelly
Radiotherapy has a role to play in the treatment of almost all malignant skin conditions and a few benign ones. Its use in the UK has been variable for several reasons. In some areas, traditional referral patterns have curtailed its use and the siting of radiotherapy departments in the larger urban areas has not given universal ease of access to all patients. Certainly radiation damage from excess radiation dose, whereby skin atrophy, telangiectasia, necrosis and ulceration even necessitated plastic surgery intervention, did occur in the past but, with better dosimetry, a wider range of radiotherapy modalities available and more careful fractionation, this is now rare.
Dermatology in practice 2002; 10(5): 16–19
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)